Prevention of venous thromboembolism

Current Opinion in Hematology

Volumn 6, Issue 5, 1999, Pages 285-290

  Rosen, S F ^a   Clagett, G P ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTICOAGULANT AGENT; ANTITHROMBIN III; DANAPAROID; ENOXAPARIN; FIBRINOGEN; HEPARIN; HIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; PROTEIN C; PROTEIN S; PROTHROMBIN; WARFARIN;

ANTICOAGULANT THERAPY; CLINICAL TRIAL; COMPRESSION THERAPY; DEEP VEIN THROMBOSIS; GENERAL SURGERY; HEART INFARCTION; HIP FRACTURE; HOSPITAL PATIENT; HUMAN; INJURY; KNEE ARTHROPLASTY; LUNG EMBOLISM; NEUROSURGERY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SPINAL CORD INJURY; STROKE; THROMBOEMBOLISM; TOTAL HIP PROSTHESIS;

HUMAN; PULMONARY EMBOLISM; VENOUS THROMBOSIS;

EID: 0033302873     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199909000-00003     Document Type: Review

References (28)

1. Prevention of venous thromboembolism
2. Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study
3. Mortality from pulmonary embolism in the United States
4. Still missing the boat with fatal pulmonary embolism
5. Pulmonary embolism and malpractice claims
6. APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or knee: A prospective study
7. Prevention of venous thromboembolism
8. Low-molecular weight heparin versus standard heparin in general and orthopedic surgery: A meta-analysis
9. Enoxaparin vs. warfarin in prevention of venous thromboembolic disease following total hip arthroplasty with inpatient and 3 month post discharge evaluation
10. Comparison of the use of foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement
11. Pre-operative versus postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip surgery
12. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement
13. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement
14. Prolonged thromboprophylaxis following hip replacement surgery: Results of a double-blind, prospective, randomized, placebo-controlled study with dalteparin (Fragmin)
15. The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: A multi-institutional cohort study of patients who underwent hip or knee arthroplasty
16. A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement
17. Prevention of thromboembolism with use of recombinant hirudin
18. For the Danaparoid Hip Arthroplasty Investigators Group A comparison of danaparoid and warfarin for prophylaxis against deep vein thrombosis after total hip replacement
19. Low molecular weight heparin decreases proximal and distal deep venous thrombosis following total knee arthroplasty: A meta-analysis of randomized trials
20. Death after proximal femoral fracture: An autopsy study
21. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery
22. A prospective study of venous thromboembolism after major trauma
23. Pulmonary embolism in major trauma patients
24. Inability of an aggressive policy of thromboprophylaxis to prevent deep venous thrombosis (DVT) in critically injured patients: Are current methods of DVT prophylaxis insufficient?
25. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma
26. Oral anticoagulation in patients with gynecological cancer and radiotherapy: A retrospective analysis of 132 patients
27. Deep venous thrombosis after orthopedic surgery in adult cancer patients